loader
Please Wait
Applying Filters...

Looking for Pharmaceutical Excipients offered by Nomisma Healthcare? Find (4R,9aS)-5-hydroxy-2-methyl-6,10-dioxo-3,4,6,9,9a,10-hexahydro-2H-1-oxa-4a,8a-diaza-anthracene-7-carboxylic acid- 2,4 difluorobenzylamide to address your drug delivery challenges on PharmaCompass.

Menu
$ API Ref.Price (USD/KG) : 414Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 2Nomisma Healthcare

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
BioProcess International Europe
Not Confirmed

02

arrow
BioProcess International Europe
Not Confirmed
arrow
BioProcess International Europe
Not Confirmed

Brand Name : PLGA-PEG

Excipient Details : PLGA-PEG is used in the synthesis of targeted nanoparticles which are used for differential delivery and controlled release of drugs.

Pharmacopoeia Ref : NA

Technical Specs : Nano-particles, ultrapure, low-monomer & powder grades.

Grade : Oral, Parenteral

arrow

Brand : PLGA-PEG

Applications : PLGA-PEG is used in the synthesis of targeted nanoparticles which are used for differential delivery and controlled release of drugs.

Pharmacopoeia Ref : NA

Technical Specs : Nano-particles, ultrapure, low-monomer & powder grades.

Grade : Oral, Parenteral

arrow
blank